HitGen Inc. (SHA:688222)
34.90
+0.25 (0.72%)
At close: Nov 17, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 14 billion as of November 16, 2026. It is the 6,278th most valuable company in the world and the 1,092nd biggest in China. Its market cap has increased by 43.36% in one year.
Market Cap
14.00B
Enterprise Value
13.34B
Revenue
705.76M
Global Rank
Country Rank
#1,092 China
PE Ratio
89.79
ChartMarket Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 14.00B, a decrease of -25.78%. That is a compound annual growth rate of -4.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 14.00B | 49.47% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hebei Changshan Biochemical Pharmaceutical | 17.18B |
| Yili Chuanning Biotechnology | 16.99B |
| Xiamen Amoytop Biotech | 16.97B |
| Evopoint Biosciences | 15.67B |
| Acrobiosystems | 14.02B |
| Sinocelltech Group | 13.95B |
| GemPharmatech | 13.29B |
| Jinyu Bio-technology | 12.98B |